Medical Cannabis Research Act of 2019
United States116th CongressHR-601House of Representatives
Updated: Mar 4, 2019
Summary
Medical Cannabis Research Act of 2019 This bill establishes a new, separate registration process for manufacturers of cannabis for research. As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers. The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
Bill texts
All available records shown.
Timeline
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
Referred to the Subcommittee on Health.
House of Representatives
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
House of Representatives